Seeking Out Game Changers in Re-Emerging Biotech Sector
April 18, 2024
Bayko, Liisa
Innovative New Cell and Gene Therapies Show Transformative Benefits
August 18, 2022
Prasad, Raju
Fund’s Active Hedging Strategy Protects Capital During Downturns
November 04, 2021
Kahn, Jordan
Gene Editing Companies Enjoy Momentum While Gene Therapies Lag
September 30, 2021
Livshits, Geulah
Several Readouts on Allogeneic Cell Therapy Expected in 2020
March 20, 2020
Prasad, Raju
Data Readouts from CRISPR Trials Will Be Critical in 2019
April 11, 2019
Samy, Manisha
Major Pharmas Becoming Increasingly Comfortable with Gene Therapy
March 22, 2019
Zhong, Yun
CRISPR and NASH Will Be Particularly Interesting and Exciting in 2019
March 15, 2019
Seedhouse, Steven
Data Consistency is Important When Investing in Gene Therapy
March 21, 2018
Chattopadhyay, Debjit
Investor Interest Coming Back to Biotech
March 19, 2018
Vandermosten, John
Gene Editing Companies Have Long-Term Potential to Be M&A Targets
March 16, 2018
Amusa, Gbola
